NCT04949802View on ClinicalTrials.gov

Glaucoma Surgery Using the ViaLase Laser System

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

December 16, 2021

Study Completion Date

December 16, 2021

Conditions
GlaucomaGlaucoma, Open-Angle
Interventions
DEVICE

ViaLase Laser

ViaLase Laser System to create an aperture through the trabecular meshwork for the reduction of IOP in subjects with primary open-angle glaucoma

Trial Locations (1)

1085

Semmeweis University Ophthalmology Clinic, Budapest

All Listed Sponsors
lead

Vialase, Inc.

INDUSTRY

NCT04949802 - Glaucoma Surgery Using the ViaLase Laser System | Biotech Hunter | Biotech Hunter